Phosphodiesterase-4 Inhibitor Roflumilast Attenuates Pulmonary Air Emboli-Induced Lung Injury.

Authors:
Chin-Pyng Wu
Chin-Pyng Wu
Tri-Service General Hospital
Taiwan
Yao-Kuang Wu
Yao-Kuang Wu
Buddhist Tzu Chi General Hospital
Taiwan
I-Shiang Tzeng
I-Shiang Tzeng
National Taiwan University
Taiwan
Chou-Chin Lan
Chou-Chin Lan
Buddhist Tzu Chi General Hospital
Taiwan

J Surg Res 2019 Apr 17;241:24-30. Epub 2019 Apr 17.

Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, School of Medicine, Tzu-Chi University, Hualien, Taiwan. Electronic address:

Background: Pulmonary air embolism (PAE)-induced acute lung injury (ALI) can be caused by massive air entry into the lung circulation. PAE can occur during diving, aviation, and some iatrogenic invasive procedures. PAE-induced ALI presents with severe inflammation, hypoxia, and pulmonary hypertension, and it is a serious complication resulting in significant morbidity and mortality. Phosphodiesterase-4 (PDE4) inhibitors can regulate inflammation and are therefore expected to have a therapeutic effect on ALI. However, the effect of the PDE4 inhibitor roflumilast on PAE-induced ALI is unknown.

Methods: The PAE model was undertaken in isolated-perfused rat lungs. Four groups (n = 6 in each group) were defined as follows: control, PAE, PAE + roflumilast 2.5 mg/kg, and PAE + roflumilast 5 mg/kg. Induction of PAE-induced ALI was achieved via the infusion of 0.7 cc air through the pulmonary artery. Roflumilast was administered via perfusate. All groups were assessed for pulmonary microvascular permeability, lung histopathology changes, pulmonary edema (lung weight/body weight, lung wet/dry weight ratio), tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1β), IL-6, IL-17, nuclear factor-kappa B (NF-κB), and inhibitor of NF-κB alpha (IκB-α).

Results: After the induction of air, PAE-induced ALI presented with pulmonary edema, pulmonary microvascular hyperpermeability, and lung inflammation with neutrophilic sequestration. The PAE-induced ALI also presented with increased expressions of IL-1β, IL-6, IL-8, IL-17, TNF-α, and NF-κB and decreased expression of IκB-α. The administration of roflumilast decreased pulmonary edema, inflammation, cytokines, NF-κB, and restored IκB-α level.

Conclusions: PAE-induced ALI presents with lung inflammation with neutrophilic sequestration, pulmonary edema, hyperpermeability, increased cytokine levels, and activation of the NF-κB pathway. Roflumilast attenuates lung edema and inflammation and downregulates the NF-κB pathway and cytokines.

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00224804193014
Publisher Site
http://dx.doi.org/10.1016/j.jss.2019.03.028DOI Listing
April 2019
6 Reads

Publication Analysis

Top Keywords

pae-induced ali
24
pulmonary edema
16
pulmonary
10
lung
9
edema inflammation
8
ali
8
neutrophilic sequestration
8
lung injury
8
inflammation neutrophilic
8
ali presented
8
pulmonary microvascular
8
nf-κb pathway
8
lung inflammation
8
il-1β il-6
8
ali presents
8
inhibitor roflumilast
8
pulmonary air
8
roflumilast attenuates
8
pae-induced
7
inflammation
6

Similar Publications